Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in AVBP — ArriVent BioPharma, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,273,915
+$994,215 QoQ
Shares Held
36,670
+202.5% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. AVBP ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,273,915 36,670
2026-03-31 $279,700 12,124
2025-12-31 $649,473 32,280
2025-09-30 $280,052 15,179
2025-06-30 $259,128 11,903
2025-03-31 $274,003 14,819
2024-12-31 $386,093 14,493
2024-09-30 $243,319 10,354
2024-06-30 $66,835 3,603
2024-03-31 $57,705 3,231